Cockrell Group's  Instablog

Cockrell Group
Send Message
The Cockrell Group, Inc. is a strategic capital markets development firm focused on small-to-midcap companies. It aligns a company's strategic goals to an institution's investment thesis and fundamentals to create a sound, long-term investment objective. The company also advises companies in... More
My company:
  • Vision-Sciences Announces Release Date Of Fourth Quarter And Full Year Fiscal 2012 Results 0 comments
    May 8, 2012 7:31 PM | about stocks: VSCI

    Vision-Sciences, Inc. (NASDAQ:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced that the Company will release its financial results for its fourth quarter and full fiscal year ended March 31, 2012, before the market opens on Tuesday, May 15, 2012, and host a conference call that same day at 8:30 a.m. Eastern Daylight Time (EDT) to discuss the results.

    Cynthia Ansari, Chief Executive Officer and Katherine Wolf, Chief Financial Officer and EVP, Corporate Development, will conduct the call.

    Conference dial-in: (877) 303-1595

    International dial-in: (970) 315-0449

    Conference ID: 79543747


    An audio replay of the conference call will be available from 11:30 a.m. EDT on Tuesday, May 15, 2012, through 11:30 p.m. EDT on Tuesday, May 29, 2012 by dialing (855) 859-2056 from the U.S. or (404) 537-3406 from abroad. The audio webcast will also be available in the investor section of the Company's website,

    About Vision-Sciences, Inc.

    Vision-Sciences, Inc. designs, develops, manufactures and markets products for endoscopy-the science of using an instrument, known as an endoscope, to provide minimally invasive access to areas not readily available to the human eye. Vision-Sciences' unique, flexible endoscopic products utilize a streamlined visualization system and proprietary sterile disposable sheaths, known as EndoSheath technology, to provide users quick, efficient endoscope turnover while ensuring enhanced patient safety through the use of sterile, single-use technology. Within its medical segment, Vision-Sciences targets five main areas for its fiber and video endoscopes and EndoSheath technology: urology, pulmonology, gastroenterology (NYSE:GI), ENT (ear, nose and throat) and spine. Vision-Sciences owns the registered trademarks Vision Sciences®, Slide-On®, EndoSheath®, EndoWipe® and the Vision System®. Information about Vision-Sciences' products is available at

    Stocks: VSCI
Back To Cockrell Group's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


  • AxoGen, Inc. $AXGN CEO Karen Zaderej, expected to appear on FOX Business' "After the Bell" with Liz Claman today at 4PM ET
    May 4, 2015
  • Bacterin $XTNT CEO on "After the Bell" with Liz Claman at 4:20PM ET
    Nov 11, 2014
  • SUPN: 2013 Revenues Exceed Analyst Company's Expectations; Maintaining Positive Outlook $SUPN
    Mar 16, 2014
More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.